Experienced in Bone Tumor

Martin R. Stockler

92-94 Parramatta Rd, 
Camperdown, NSW, AU 
Experienced in Bone Tumor
92-94 Parramatta Rd, 
Camperdown, NSW, AU 
OverviewLocationsClinical Research

Overview

Martin Stockler practices in Camperdown, Australia. Mr. Stockler is rated as an Experienced expert by MediFind in the treatment of Bone Tumor. His top areas of expertise are Testicular Cancer, Prostate Cancer, Ovarian Cancer, Nephrectomy, and Prostatectomy.

His clinical research consists of co-authoring 234 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Bone Tumor.

Gender
Male

Locations

92-94 Parramatta Rd, Camperdown, NSW 2050, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Randomised Phase 3 Trial of Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer: ENZAMET
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2025
Intervention Type: Drug
Study Drugs: Enzalutamide, Non-Steroidal Anti Androgen, Luteinizing Hormone Releasing Hormone Analog or Surgical Castration
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3
A Phase II Trial of Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase II Trial of Biomarker-driven Intermittent Docetaxel in Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment Status: Terminated
Publish Date: November 22, 2024
Intervention Type: Drug
Study Drug: Docetaxel
Study Phase: Phase 2
View 2 Less Clinical Trials

233 Total Publications

Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer.
Target trial emulation of early docetaxel and enzalutamide for metastatic hormone-sensitive prostate cancer.
Journal: BJU international
Published: November 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Stockler's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 18 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile